Eli Lilly announced the acquisition of a biotechnical research company involved in research and development of an anti-CGRP drug. Since 2004, Tuliv migraine research, the makers of Tuliv Migraine Defense, have been advocating this approach to migraine prevention not only in published articles, but in the formulation of the migraine prevention product, Migraine Defense.
What is Anti-CGRP and why is it important?
In 2003, Tuliv (under its former name Christian Body Research - CBR) discovered the chemical CGRP in its relationship to migraines and believed it to be the biological chemical responsible for the onset of migraines. As evidence from other studies confirmed this idea, CBR began trials to determine which natural ingredients combined in a formula could be used to control or prevent migraines from occurring.
Today thousands of men, women and children have been helped by the Tuliv Migraine Defense product for the prevention of migraines. To learn more why anti-CGRP is the proper approach to migraine prevention see anti-CGRP migraine prevention.
If you are thinking about starting Tuliv Migraine Defense for the first time or are ready to reorder we welcome your calls 1-866-367-5953 to help you get started, complete a migraine profile interview or answer all your questions.
Visit our new web site at the same address www.Tuliv.com.
|
